NCPA, other groups: New rebate rule doesn’t do enough

NCPA November 24, 2020

Five of the nation’s leading pharmacy groups, including NCPA, issued a statement Tuesday expressing disappointment with the Trump administration’s new final rule on prescription drug rebates. The statement read, in part: “While we want our patients to pay less for their prescription drugs, this rule does not accomplish that. It will likely increase their insurance premiums and out-of-pocket costs and may limit patients’ access to care by forcing more pharmacies to close.” Read the full statement here. NCPA, along with the American Pharmacists Association, National Association of Specialty Pharmacy, FMI-The Food Industry Association, and the National Grocers Association, also stressed in a July 2020 statement that any rule change needed to address pharmacy DIR fees.